Inferior vena cava (IVC) filters are surgically implanted medical devices used to prevent blood clots from migrating towards the lungs. These devices look like small wire cages, and they operate by catching blood clots traveling through the body before the clots reach vital organs and cause serious injury. IVC filters are implanted in people who have a history of developing blood clots, but who cannot tolerate blood thinner medications.
Despite the popularity of these devices as a means to treat blood clot risks in certain patient populations, there have been a large number of adverse events reported to the U.S. Food and Drug Administration (FDA) regarding these devices. These devices are causing major issues because pieces are breaking off, migrating and puncturing vital organs and veins.
IVC filters are implanted in roughly a quarter of a million U.S. patients each year even though research shows patients still suffer from deep vein thrombosis and pulmonary embolisms. There is a lack of long-term studies that show that IVC filters are safe and effective.
There are many complications that have been reported to the FDA. The FDA has received over 900 reports since 2005. Some of those complications include filter fractures, aortic perforations, vena cava punctures, tissue perforations, and migration of the filter to other parts of the body. Read our blog post for more information.
Andrus Wagstaff, PC is investigating potential claims in regards to complications from IVC filter implantations. Please contact us by using the online form or by calling our office at 866-795-9529 so that we may better evaluate your claim.
